Thomas London has joined the board of Oslo Cancer Cluster Incubator
“It was an honour to be elected to the board,” Thomas London said.
London is a businessman who has been trying to buy property from Oslo municipality to expand Oslo Cancer Cluster Innovation Park to make room for more businesses and laboratories within the cancer sphere. The slow process now seems to have found a solution with the new Oslo City Council.
Read about the assurances from the City Council in the newspaper Dagsavisen (in Norwegian).
An active board member
London underlines the value for society in having an incubator dedicated to new companies working with cancer, often developing innovative Norwegian cancer research.
“The work of the incubator affects many lives and will continue doing so in the future. I wish to be an active board member and support the work of the incubator team in developing the incubator to be even bigger and help even more start-up companies through their first critical years.”
There is also a personal reason why Thomas London was eager to take on a board position in the incubator. Like so many, he has had close relations get cancer.
“I am personally invested in the fight against cancer and in developing better cancer care.”
Expanding the innovation park
As the manager of the real estate development company Oslo Science Hub AS, he oversees the final expansion of Oslo Cancer Cluster Innovation Park. The final expansion is planned to be about 40,000 square metres. London is sure that cancer innovation in Norway will grow with the park.
“In the coming years it will be easier to see the entire Campus Radiumhospitalet as one innovative area,” London said.
You can read more about the expansion plans, and see the building site live, at the Oslo Cancer Cluster Innovation Park website.